|
1
|
Bray F, Laversanne M, Sung H, Ferlay J,
Siegel RL, Soerjomataram I and Jemal A: Global cancer statistics
2022: GLOBOCAN estimates of incidence and mortality worldwide for
36 cancers in 185 countries. CA Cancer J Clin. 74:229–263.
2024.PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016.PubMed/NCBI
|
|
3
|
Cao M and Chen W: Epidemiology of lung
cancer in China. Thorac Cancer. 10:3–7. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Asamura H, Nishimura KK, Giroux DJ,
Chansky K, Hoering A, Rusch V and Rami-Porta R; Members of the
IASLC Staging, Prognostic Factors Committee of the Advisory Boards,
Participating Institutions, : IASLC Lung cancer staging project:
The new database to inform revisions in the ninth edition of the
TNM classification of lung cancer. J Thorac Oncol. 18:564–575.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pirker R: Chemotherapy remains a
cornerstone in the treatment of nonsmall cell lung cancer. Curr
Opin Oncol. 32:63–67. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Powell SF, Rodríguez-Abreu D, Langer CJ,
Tafreshi A, Paz-Ares L, Kopp HG, Rodríguez-Cid J, Kowalski DM,
Cheng Y, Kurata T, et al: Outcomes with pembrolizumab plus
platinum-based chemotherapy for patients with NSCLC, sTable brain
metastases: Pooled analysis of KEYNOTE-021, −189, and −407. J
Thorac Oncol. 16:1883–1892. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Forde PM, Spicer J, Lu S, Provencio M,
Mitsudomi T, Awad MM, Felip E, Broderick SR, Brahmer JR, Swanson
SJ, et al: Neoadjuvant nivolumab plus chemotherapy in resecTable
lung cancer. N Engl J Med. 386:1973–1985. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang C, Qiao W, Jiang Y, Zhu M, Shao J,
Wang T, Liu D and Li W: The landscape of immune checkpoint
inhibitor plus chemotherapy versus immunotherapy for advanced
non-small-cell lung cancer: A systematic review and meta-analysis.
J Cell Physiol. 235:4913–4927. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jiang J, Wang Y, Gao Y, Sugimura H,
Minervini F, Uchino J, Halmos B, Yendamuri S, Velotta JB and Li M:
Neoadjuvant immunotherapy or chemoimmunotherapy in non-small cell
lung cancer: A systematic review and meta-analysis. Transl Lung
Cancer Res. 11:277–294. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
NSCLC Meta-analysis Collaborative Group, .
Preoperative chemotherapy for non-small-cell lung cancer: A
systematic review and meta-analysis of individual participant data.
Lancet. 383:1561–1571. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lavan AH, O'Mahony D, Buckley M, O'Mahony
D and Gallagher P: Adverse drug reactions in an oncological
population: Prevalence, predictability, and preventability.
Oncologist. 24:e968–e977. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu M, Wu Y, Chen Y, Sun J, Zhao Z, Chen
XW, Matheny ME and Xu H: Large-scale prediction of adverse drug
reactions using chemical, biological, and phenotypic properties of
drugs. J Am Med Inform Assoc. 19:e28–e35. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang Z, Clark NR and Ma'ayan A:
Drug-induced adverse events prediction with the LINCS L1000 data.
Bioinformatics. 32:2338–2345. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Luo H, Fokoue-Nkoutche A, Singh N, Yang L,
Hu J and Zhang P: Molecular docking for prediction and
interpretation of adverse drug reactions. Comb Chem High Throughput
Screen. 21:314–322. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Blonde L, Khunti K, Harris SB, Meizinger C
and Skolnik NS: Interpretation and impact of real-world clinical
data for the practicing clinician. Adv Ther. 35:1763–1774. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shickel B, Tighe PJ, Bihorac A and Rashidi
P: Deep EHR: A survey of recent advances in deep learning
techniques for Electronic Health Record (EHR) analysis. IEEE J
Biomed Health Inform. 22:1589–1604. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rajkomar A, Oren E, Chen K, Dai AM, Hajaj
N, Hardt M, Liu PJ, Liu X, Marcus J, Sun M, et al: Scalable and
accurate deep learning with electronic health records. NPJ Digit
Med. 1:182018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Choi E, Schuetz A, Stewart WF and Sun J:
Using recurrent neural network models for early detection of heart
failure onset. J Am Med Inform Assoc. 24:361–370. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bernardini M, Romeo L, Misericordia P and
Frontoni E: Discovering the type 2 diabetes in electronic health
records using the sparse balanced support vector machine. IEEE J
Biomed Health Inform. 24:235–246. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tseng PY, Chen YT, Wang CH, Chiu KM, Peng
YS, Hsu SP, Chen KL, Yang CY and Lee OK: Prediction of the
development of acute kidney injury following cardiac surgery by
machine learning. Crit Care. 24:4782020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu X, Zheng D, Zhong Y, Xia Z, Luo H and
Weng Z: Machine-learning prediction of oral drug-induced liver
injury (DILI) via multiple features and endpoints. Biomed Res Int.
2020:47951402020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pedregosa F, Varoquaux G, Gramfort A,
Michel V, Thirion B, Grisel O, Blondel M, Prettenhofer P, Weiss R,
Dubourg V, et al: Scikit-learn: Machine learning in python. J Mach
Learn Res. 12:2825–2830. 2011.
|
|
23
|
Virtanen P, Gommers R, Oliphant TE,
Haberland M, Reddy T, Cournapeau D, Burovski E, Peterson P,
Weckesser W, Bright J, et al: Author correction: SciPy 1.0:
Fundamental algorithms for scientific computing in python. Nat
Methods. 17:3522020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Huang S, He T, Yang S, Sheng H, Tang X,
Bao F, Wang Y, Lin X, Yu W, Cheng F, et al: Metformin reverses
chemoresistance in non-small cell lung cancer via accelerating
ubiquitination-mediated degradation of Nrf2. Transl Lung Cancer
Res. 9:2337–2355. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Murphy KP: Machine learning: A
probabilistic perspective. The MIT Press; Cambridge, Massachusetts:
2012
|
|
26
|
Carr DF and Pirmohamed M: Biomarkers of
adverse drug reactions. Exp Biol Med (Maywood). 243:291–299. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kheifetz Y and Scholz M: Individual
prediction of thrombocytopenia at next chemotherapy cycle:
Evaluation of dynamic model performances. Br J Clin Pharmacol.
87:3127–3138. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang Y, Zhang R, Shen Y, Su L, Dong B and
Hao Q: Prediction of chemotherapy adverse reactions and mortality
in older patients with primary lung cancer through frailty index
based on routine laboratory data. Clin Interv Aging. 14:1187–1197.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Dranitsaris G, Molassiotis A, Clemons M,
Roeland E, Schwartzberg L, Dielenseger P, Jordan K, Young A and
Aapro M: The development of a prediction tool to identify cancer
patients at high risk for chemotherapy-induced nausea and vomiting.
Ann Oncol. 28:1260–1267. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Boudali I and Messaoud IB: Machine
learning models for toxicity prediction in chemotherapy.
Intelligent Systems Design and Applications. Springer Nature
Switzerland Cham; pp. 350–364. 2023, View Article : Google Scholar
|
|
31
|
Wu Y, Zhao W, Zhang L, Wang Y, Wen Y and
Liu L: Machine learning models for predicting chemotherapy-induced
adverse drug reactions in colorectal cancer patients. Dig Liver
Dis. 57:1845–1852. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Polevikov S: Advancing AI in healthcare: A
comprehensive review of best practices. Clin Chim Acta.
548:1175192023. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Adlung L, Cohen Y, Mor U and Elinav E:
Machine learning in clinical decision making. Med. 2:642–665. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kline A, Wang H, Li Y, Dennis S, Hutch M,
Xu Z, Wang F, Cheng F and Luo Y: Multimodal machine learning in
precision health: A scoping review. NPJ Digit Med. 5:1712022.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zheng S, Zhu Z, Liu Z, Guo Z, Liu Y, Yang
Y and Zhao Y: Multi-modal graph learning for disease prediction.
IEEE Trans Med Imaging. 41:2207–2216. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Luscher TF, Wenzl FA, D'Ascenzo F,
Friedman PA and Antoniades C: Artificial intelligence in
cardiovascular medicine: Clinical applications. Eur Heart J.
45:4291–4304. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Petzl AM, Jabbour G, Cadrin-Tourigny J,
Pürerfellner H, Macle L, Khairy P, Avram R and Tadros R: Innovative
approaches to atrial fibrillation prediction: Should polygenic
scores and machine learning be implemented in clinical practice?
Europace. 26:euae2012024. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Couckuyt A, Seurinck R, Emmaneel A,
Quintelier K, Novak D, Van Gassen S and Saeys Y: Challenges in
translational machine learning. Human Genetics. 141:1451–1466.
2022. View Article : Google Scholar : PubMed/NCBI
|
